Effect of dose timing in relation to food intake on systemic exposure to blonanserin

Authors:

Abstract
Blonanserin is a novel potent dopamine D2 and serotonin 5-HT2 antagonist for treating schizophrenia. The aim of this study was to investigate prandial effects on systemic exposure to blonanserin in healthy volunteers, with particular attention paid to the effect of dose timing relative to meal intake.

This publication has 11 references indexed in Scilit: